UBS Group’s Heliogen, Inc. HLGN Stock Holding History

UBS Group’s Portfolio HLGN Stock Details HLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21	Closed	-$79	–	10457
2023 Q3	$79	Sell	21 -416	-95%	-$3.03K	﹤0.01%	8936
2023 Q2	$3.75K	Sell	437 -228	-34%	-$2.09K	﹤0.01%	7608
2023 Q1	$5.59K	Sell	665 -29	-4%	-$440	﹤0.01%	8017
2022 Q4	$17K	Buy	694 +648	+1,409%	+$29.2K	﹤0.01%	7862
2022 Q3	$3K	Sell	46 -135	-75%	-$10.5K	﹤0.01%	9638
2022 Q2	$13K	Sell	181 -21	-10%	-$2.73K	﹤0.01%	7589
2022 Q1	$37K	Buy	202 +186	+1,163%	+$34K	﹤0.01%	6807
2021 Q4	$9K	Sell	16 -4	-20%	-$1.4K	﹤0.01%	8966
2021 Q3	$7K	Buy	20 +14	+233%	+$4.85K	﹤0.01%	8356
2021 Q2	$2K	Buy	+6	New	+$2.04K	﹤0.01%	9022

Other funds holding HLGN

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

CFG

CKW Financial Group Honolulu, Hawaii $1.02B AUM 21.34% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

PWM

Partnership Wealth Management Towson, Maryland $148M AUM 31.4% 1-Year Est. Return

UBS Group's HLGN Position: Q4 2023 in Review

UBS Group sold out of Heliogen, Inc. (HLGN) in Q4 2023, closing a stake of 21 shares — an estimated $79 sold.

UBS Group first reported a position in HLGN in Q2 2021 and held it in 10 quarters. The position peaked at $37K in Q1 2022. 5 funds tracked by Wall St. Rank hold HLGN as of Q4 2023.

UBS Group reported no remaining Heliogen, Inc. position as of Q4 2023 after selling out during the quarter.
UBS Group sold 21 Heliogen, Inc. shares in Q4 2023, an estimated $79.
UBS Group first reported a position in Heliogen, Inc. in Q2 2021 and held it in 10 quarters.
UBS Group's Heliogen, Inc. position peaked at $37K in Q1 2022.
5 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.